DIAN Pharma Consortium

Investigational drugs chosen for major Alzheimer’s prevention trial

Thursday, October 11, 2012

Scientists have selected the first investigational drugs for a worldwide Alzheimer’s disease prevention trial. The pioneering study, expected to start by early 2013, initially will test three promising drugs—gantenerumab, solanezumab and an unnamed BACE inhibitor—each designed to target Alzheimer’s in different ways.

[Read More]